Indian Pacing Electrophysiol. J. ISSN Current Status of Internal Cardioversion in Atrial Fibrillation
|
|
- Gyles Barton
- 5 years ago
- Views:
Transcription
1 Page 1 of 7 Indian Pacing Electrophysiol. J. ISSN Indian Pacing Electrophysiol. J. 2002;2(2):40 Review Article Current Status of Internal Cardioversion in Atrial Fibrillation Andreas Plewan, MD and Eckhard Alt, MD Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München, Germany. Address for correspondence: Prof E Alt, Medizinische Klinik, Klinikum rechts der Isar, Ismaningerstr 22, München, Germany. E mail: alt@med1.med.tu-muenchen.de Keywords: atrial fibrillation, internal cardioversion For more than 30 years transthoracic external cardioversion has been an established method for the restoration of sinus rhythm in patients with persistent atrial fibrillation. It was first described by Lown in Though the success rate for external cardioversion ranges from % 2,3,4, there is reduced efficacy in those patients with a high body-mass index and an increased transthoracic diameter 5. The method of internal cardioversion for restoration of sinus rhythm using transvenous electrodes has been reported in several animal 6,7 and human studies 8,9,10,11,12,13,14,15. Cooper et al 6 tested multiple electrode configurations in a sheep model of atrial fibrillation. They demonstrated that the optimal single current pathway for internal atrial defibrillation employed two electrodes that surrounded both atria (e.g., right atrial appendage and distal coronary sinus). Similar results have been reported in several human studies 12,13,14. Internal cardioversion has been shown to be superior to conventional external cardioversion in terms of primary success rate, energy requirements and the need for sedation; this superiority holds especially true for patients with a high body mass index of > 25 kg/m2 and increased transthoracic diameter 1
2 Page 2 of 7 The initial human data has been collected using two separate catheter for internal cardioversion. Though this approach demonstrated some advantages, there are also clear disadvantages, such as lack of ventricular backup stimulation in cases of post shock bradycardia, prolonged fluoroscopy time and the need for venous access via primarily the lower limb. These disadvantages increase the risk of bleeding complications, especially in patients with anticoagulation. Recently published data have demonstrated the benefit of a single lead catheter with two shock arrays on a balloon guided pulmonary artery catheter, when compared to the previous two catheter technique 12. Optional ventricular backup pacing, preferable venous access via the upper limb, reduced procedural and fluoroscopy time are the major advantages. This new balloon-tipped cardioversion catheter (fig 1 and 2) resembles a regular Swan-Ganz catheter. A guide-wire introduced via a central lumen allows facilitated searing and positioning of this device. The central lumen also provides means to draw blood samples, infuse drugs or perform haemodynamic measurements (pulmonary artery and wedge pressure). The proximal and distal high-energy electrode arrays for internal defibrillation consist of six 0.5 cm long platinum rings with a total surface area of 2.4 cm2 for each array. The middle ring of the proximal array is connected individually for atrial sensing and pacing, while the others are connected in parallel (atrial array). One pole located in the right ventricular outflow tract - between both arrays - serves for ventricular pacing and sensing. The six distal pulmonary rings are connected in parallel for internal cadioversion shock delivery.
3 Page 3 of 7 Figure 1: Single lead ballon guided cardioversion catheter introduced via the right cubital vein. The proximal shock array contacts the basal right atrial wall and the distal shock array is positioned in the left pulmonary artery
4 Page 4 of 7 Figure 2: Same patient as in figure 1. The distal shock array is in the right pulmonary artery in a position similar to a regular Swan Ganz catheter for haemodynamic monitoring. For cardioversion with this new device an electrode configuration in the right atrium and left pulmonary artery is suggested. A randomized trial could demonstrate that this configuration provides a homogeneous electrical field for effective cardioversion, and slightly higher energy requirements compared to a lead position in the right atrium and distal coronary sinus 12, as described earlier. However the use of single lead catheters with a shock array position proximal in the right atrium and distal in the left pulmonary artery has contributed to facilitate the procedure of internal cardioversion of atrial fibrillation considerably. Ventricular backup pacing is an important safety tool, not only for a subgroup of patients with post shock bradycardia, but also for bradycardia after the administration of antiarrhythmic drugs or beta-blockers. The possibility of post shock atrial pacing also offers new therapeutic options in preventing the early recurrence of atrial fibrillation. Immediately
5 Page 5 of 7 after cardioversion 60% of all patients develop premature atrial contractions 16. Recently published data suggest that short coupling intervals of the premature atrial beat predict an early relapse of atrial fibrillation 16. Heterogeneity of refractoriness and conduction give way for a premature stimulus to reinduce atrial fibrillation. Immediately after cardioversion, electrical remodeling has shortened the refractory period of the atria, thereby facilitating relapse 16,17. Atrial overdrive stimulation after successful internal cardioversion for the prevention of atrial premature beats promotes the homogeneity of the atrial wavefront. Atrial stimulation at higher rates therefore can prevent early recurrence of atrial fibrillation, thereby contributing to the clinical efficacy of internal cardioversion 18. For internal cardioversion of atrial fibrillation an electrode position with the distal tip in the left pulmonary artery is currently used preferably (fig 1). Due to the manufactured curvature of the Swan-Ganz type catheter, this catheter has the tendency to favor the right pulmonary artery when advanced normally. Therefore the use of a lead configuration in the right atrium and right pulmonary artery would facilitate the procedure of internal cardioversion (fig 2). A recently finished study at the Rechts der Isar Medical Center in Munich revealed that the efficacy of internal cardioversion of atrial fibrillation with the distal shock array in the right pulmonary artery is 88 %. This success rate is somewhat lower than for a positioning in the left pulmonary artery. The reason for this difference might only be anticipated. The creation of a homogenous electrical field with sufficient strength is mandatory for conversion of ventricular fibrillation 13. The same may hold true for AF. With respect to homogeneity of field strength, one would assume that direct application of the energy to the two areas within or surrounding the heart should result in increased myocardial field strength and decreased energy loss. While an electrode position in the right atrium and left pulmonary artery creates an electric field vector encompassing large areas of both atria, an electrode position right atrium and right pulmonary artery does not include parts of the left lateral atrium. This exclusion results in a loss of homogeneity of the electric field strength and therefore mandates slightly higher cardioversion energies. Nevertheless, the success rates for internal cardioversion with the distal tip in the right pulmonary artery is comparable to the efficacy of external cardioversion. This lead position furthermore facilitates the internal cardioversion procedure, because the positioning of the single lead balloon tipped cardioversion catheter in the right pulmonary artery is comparable to the positioning of a regular Swan-Ganz catheter. Though the design of the cardioversion catheter is similar to a regular Swan-Ganz balloon catheter, the cardioversion catheter offers the additional facilities of cardioversion, cardiac pacing and, in the newest generation of these electrode systems even haemodynamic measurements by means of thermodilution. These qualities render the cardioversion catheter suited for application in the electrophysiological laboratory as well as in emergency and intensive care settings. More than 30 % of patients undergoing cardiovascular surgery develop persistent atrial fibrillation 20. In these settings, the new device combines not only routine haemodynamic monitoring, identical to a regular Swan-Ganz catheter, but also offers means for effectively cardioverting atrial fibrillation without the assistance of an anesthesiologist, a widespread prerequisite for external cardioversion procedures in outpatient departments. The balloon guided single lead cardioversion catheter offers a valid alternative to external cardioversion, and can be operated by non-cardiologist as well. Currently ongoing studies assess the value of the combined Swan-Ganz thermodilution and cardioversion-catheter in the postoperative ICU-setting.
6 Page 6 of 7 References 1. Lown B, Amarasingham R, Neumann J (1962) New method for terminating cardiac arrythmias use of synchronized capacitor discharge. JAMA 182: Lundstrom T, Ryden L (1988) Chronic atrial fibrillation: long term results of direct current cardioversion. Acta Med Scand 223: Dalzel GWN, Anderson J, Adgey AAJ (1990) Factors determining success and enrgy requiremnets for cardioversion of atrial fibrillation. Q J Med 76: Morris JJ Jr, Pater RH, McIntosh HD (1966) Electrical cardioversion of atrial fibrillation: immediate and long-term results and selection of patients. Ann Intern Med 65: Schmitt C, Alt E, Plewan A, et al. (1996) Low-energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation. Am J Cardiol 28: Cooper RAS, Alferness CA, Smith WA et al. (1993) Internal cardioversion of atrial fibrillation in sheep. Circulation 87: Powell AC, Garan H, Mc Govern BA, et al. (1992) Low energy conversion of atrial fibrillation in the sheep. Am J Cardiol 20: Alt E, Schmitt C, Ammer R, et al. (1994) Initial experience with intracardiac atrial defibrillation in patients with chronic atrial fibrillation. PACE 17: Alt E, Ammer R, Lehmann G, et al. (1997) Patient characteristics and underlying heart disease as predictors of recurrent atrial fibrillation following internal and external cardioversion. Am Heart J 134: Levy S, Laurive P, Dolla E, et al. (1992) A randozimed comparison of external and internal cardioversion of chronic atrial fibrillation. Circulation 86: Alt E, Ammer R, Lehmann G, Schmitt C, Pasquantonio J, Schömig A (1998) Efficacy of a new balloon catheter for internal cardioversion of chronic atrial fibrillation without anaesthesia. Heart 79: Alt E, Schmitt C, Ammer R, et al. (1997) Effect of electrode position on outcome of low-energy intracardiac cardioversion of treatment of atrial fibrillation. Am J Cardiol 79: Ideker RE, Wolf PD, Alterness CA, et al. (1991) Current concepts for selecting the location, size, and shape of defibrillation electrodes. PACE 14: Levy S, Ricard P, Lau CP, Lok NS, Camm AJ, Murgatroyd FD, Jordaens LJ, Kappenberger LJ, Brugada P, Ripley KL (1997) Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation. JACC 29:750-55
7 Page 7 of Alt E, Ammer R Schmitt C, Evans F, Lehmann G, Pasquantonio J und Schömig A (1997) A comparsion of atrial fibrillation with low energy intracardiac cardioversion and conventional external cardioversion. Eur Heart J 18: Tieleman RG, Van Gelder IC, Crijns HJGM, Kam PJ, Van den Berg MP, Haaksma J, Van der Woude HJ, Allessie MA (1998) Early recurrence of atrial fibrillation after electrical cardioversion: a result of fibrillation induced electrical remodeling of the atria? J Am Coll Cardiol 31: Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA (1995) Atrial fibrillation begets atrial fibrillation: A study on awake chronically instrumented goats. Circulation 92: Plewan A, Valina C, Herrmann R, Alt E (1999) Initial experience with a new balloonguided single lead catheter for internal cardioversion of atrial fibrillation and dual chamber pacing. Pacing Clin Electrophysiol. 22(1Pt2): CPlewan A, Karch M, Alt E (2000) Effect of lead position on outcom of internal cardioversion of atrial fibrillation: right vs. left pulmonary artery. Pacing Clin Electrophysiol. 23 (abs.) Daoud EG, Strickberger A, Ching Man K, et al. (1997) Preoperative Amiodarone as prophylaxis against atrial fibrillation after heart surgery N Engl J Med 337:
INTERNAL CARDIOVERSION. Lancashire & South Cumbria Cardiac Network
INTERNAL CARDIOVERSION Lancashire & South Cumbria Cardiac Network DC Cardioversion AF & AFL safe 1,2 efficacious 3,4 (60-94%) 5 SR - Increases exercise tolerance 6 Maintainence SR unlikely in patients
More informationInitial Clinical Experience With Ambulatory Use of an Implantable Atrial Defibrillator for Conversion of Atrial Fibrillation
Initial Clinical Experience With Ambulatory Use of an Implantable Atrial Defibrillator for Conversion of Atrial Fibrillation Emile G. Daoud, MD; Carl Timmermans, MD; Chris Fellows, MD; Robert Hoyt, MD;
More informationAtrial fibrillation (AF) is the most common sustained
Atrioverter: An Implantable Device for the Treatment of Atrial Fibrillation Hein J.J. Wellens, MD; Chu-Pak Lau, MD; Berndt Lüderitz, MD; Masood Akhtar, MD; Albert L. Waldo, MD; A. John Camm, MD; Carl Timmermans,
More informationAtrial fibrillation (AF) has a tendency to become more
Reversal of Atrial Electrical Remodeling After Cardioversion of Persistent Atrial Fibrillation in Humans W. Julian C. Hobbs, MB; Simon Fynn, MB; Derick M. Todd, MB; Peter Wolfson, MB; Mike Galloway, BS;
More informationMechanism of Immediate Recurrences of Atrial Fibrillation After Restoration of Sinus Rhythm
Mechanism of Immediate Recurrences of Atrial Fibrillation After Restoration of Sinus Rhythm AMAN CHUGH, MEHMET OZAYDIN, CHRISTOPH SCHARF, STEVE W.K. LAI, BURR HALL, PETER CHEUNG, FRANK PELOSI, JR, BRADLEY
More informationAtrial Defibrillation With a Transvenous Lead A Randomized Comparison of Active Can Shocking Pathways
Journal of the American College of Cardiology Vol. 34, No. 2, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00214-4 Atrial
More informationAF :RHYTHM CONTROL BY DR-MOHAMMED SALAH ASSISSTANT LECTURER CARDIOLOGY DEPARTMENT
AF :RHYTHM CONTROL BY DR-MOHAMMED SALAH ASSISSTANT LECTURER CARDIOLOGY DEPARTMENT 5-2014 Atrial Fibrillation therapeutic Approach Rhythm Control Thromboembolism Prevention: Recommendations Direct-Current
More informationImplantable Atrial Defibrillator With a Single-Pass Dual-Electrode Lead
Journal of the American College of Cardiology Vol. 33, No. 7, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00138-2 Implantable
More informationAF and arrhythmia management. Dr Rhys Beynon Consultant Cardiologist and Electrophysiologist University Hospital of North Staffordshire
AF and arrhythmia management Dr Rhys Beynon Consultant Cardiologist and Electrophysiologist University Hospital of North Staffordshire Atrial fibrillation Paroxysmal AF recurrent AF (>2 episodes) that
More informationEarly Recurrence of Atrial Fibrillation After Ambulatory Shock Conversion
Journal of the American College of Cardiology Vol. 40, No. 1, 2002 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(02)01912-5
More informationImplantable Cardioverter-Defibril. Defibrillators. Ratko Magjarević
Implantable Cardioverter-Defibril Defibrillators Ratko Magjarević University of Zagreb Faculty of Electrical Engineering and Computing Croatia ratko.magjarevic@fer.hr Ventricular Fibrillation Ventricular
More informationAtrial fibrillation or atrial flutter (AF) may occur after
Relation of Atrial Refractoriness to Upper and Lower Limits of Vulnerability for Atrial Fibrillation/Flutter Following Implantable Ventricular Defibrillator Shocks Amos Katz, MD; Robert J. Sweeney, PhD;
More informationFigure 2. Normal ECG tracing. Table 1.
Figure 2. Normal ECG tracing that navigates through the left ventricle. Following these bundle branches the impulse finally passes to the terminal points called Purkinje fibers. These Purkinje fibers are
More informationVErapamil Plus Antiarrhythmic drugs Reduce Atrial Fibrillation recurrences after an electrical cardioversion (VEPARAF Study)
European Heart Journal (2003) 24, 1425 1429 VErapamil Plus Antiarrhythmic drugs Reduce Atrial Fibrillation recurrences after an electrical cardioversion (VEPARAF Study) Antonio De Simone a, Michele De
More informationAtrial Fibrillation: Rate vs. Rhythm. Michael Curley, MD Cardiac Electrophysiology
Atrial Fibrillation: Rate vs. Rhythm Michael Curley, MD Cardiac Electrophysiology I have no relevant financial disclosures pertaining to this topic. A Fib Epidemiology #1 Most common heart rhythm disturbance
More informationNovel Passive Implantable Atrial Defibrillator Using Transcutaneous Radiofrequency Energy Transmission Successfully Cardioverts Atrial Fibrillation
Novel Passive Implantable Atrial Defibrillator Using Transcutaneous Radiofrequency Energy Transmission Successfully Cardioverts Atrial Fibrillation Ganesh Manoharan, MD; Noel Evans, PhD; Bakthiar Kidwai,
More informationAlthough the amount of energy needed for internal
Effect of Tartrate on Shock-Related Discomfort During Internal Atrial Defibrillation Carl Timmermans, MD; Luz-Maria Rodriguez, MD; Gregory M. Ayers, MD; Hendrik Lambert, PhD; Joep L.R.M. Smeets, MD; Johan
More informationExternal Cardioversion in Patients With Persistent Atrial Fibrillation
External Cardioversion in Patients With Persistent Atrial Fibrillation A Reappraisal of the Effects of Electrode Pad Position and Transthoracic Impedance on Cardioversion Success Chien-Jen CHEN, 1 MD,
More informationΚΟΛΠΙΚΗ ΜΑΡΜΑΡΥΓΗ ΦΑΡΜΑΚΕΥΤΙΚΗ ΗΛΕΚΤΡΙΚΗ ΑΝΑΤΑΞΗ. ΣΠΥΡΟΜΗΤΡΟΣ ΓΕΩΡΓΙΟΣ Καρδιολόγος, Ε/Α, Γ.Ν.Κατερίνης. F.E.S.C
ΚΟΛΠΙΚΗ ΜΑΡΜΑΡΥΓΗ ΦΑΡΜΑΚΕΥΤΙΚΗ ΗΛΕΚΤΡΙΚΗ ΑΝΑΤΑΞΗ ΣΠΥΡΟΜΗΤΡΟΣ ΓΕΩΡΓΙΟΣ Καρδιολόγος, Ε/Α, Γ.Ν.Κατερίνης. F.E.S.C Definitions of AF: A Simplified Scheme Term Definition Paroxysmal AF AF that terminates
More informationEHRA/EUROPACE 2011 Madrid, Spain June
EHRA/EUROPACE 2011 Madrid, Spain June 26.-29.2011 Implementing modern management in atrial fibrillation patients Proceedings from the 3rd AFNet/EHRA consensus conference EHRA Special Session Different
More informationBiatrial Stimulation and the Prevention of Atrial Fibrillation
374 September 2001 Biatrial Stimulation and the Prevention of Atrial Fibrillation L. MELCZER Heart Institute, Faculty of Medicine, University of Pécs, Pécs, Hungary I. LORINCZ 1 st Internal Department,
More informationTreatment of Atrial Fibrillation in Heart Failure
Stockholm, September 1st 2010 Treatment of Atrial Fibrillation in Heart Failure Rhythm control: Which drugs? Stefan H. Hohnloser J.W. Goethe University Frankfurt, Germany Presenter disclosure information:
More informationCatheter Ablation: Atrial fibrillation (AF) is the most common. Another Option for AF FAQ. Who performs ablation for treatment of AF?
: Another Option for AF Atrial fibrillation (AF) is a highly common cardiac arrhythmia and a major risk factor for stroke. In this article, Dr. Khan and Dr. Skanes detail how catheter ablation significantly
More informationRaphael Rosso MD, Yuval Levi Med. Eng., Sami Viskin MD Tel Aviv Sourasky Medical Center
Radiofrequency Ablation of Atrial Fibrillation: Comparison of Success Rate of Circular Ablation vs Point-by-Point Ablation with Contact Force Assessment in Paroxysmal and Persistent Atrial Fibrillation
More informationLow efficacy of cardioversion of persistent atrial fibrillation with the implantable cardioverter-defibrillator
Neth Heart J (2013) 21:548 553 DOI 10.1007/s12471-013-0474-z ORIGINAL ARTICLE-E-LEARNING Low efficacy of cardioversion of persistent atrial fibrillation with the implantable cardioverter-defibrillator
More informationPlanning and monitoring of patients for electrical cardioversion for atrial fibrillation
Neth Heart J (2012) 20:148 154 DOI 10.1007/s12471-011-0208-z ORIGINAL ARTICLE Planning and monitoring of patients for electrical cardioversion for atrial fibrillation J. H. H. Deuling & R. P. Vermeulen
More informationJournal of the American College of Cardiology Vol. 37, No. 5, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 37, No. 5, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01132-9 Increased
More informationAtrial fibrillation: the remodelling phenomenon
European Heart Journal Supplements (2003) 5 (Supplement H), H1 H7 Atrial fibrillation: the phenomenon G.L. Botto, M. Luzi and A. Sagone Department of Cardiology, St Anna Hospital, Como, Italy KEYWORDS
More informationAtrial fibrillation: the remodelling phenomenon
European Heart Journal Supplements (2003) 5 (Supplement H), H1 H7 Atrial fibrillation: the phenomenon G.L. Botto, M. Luzi and A. Sagone Department of Cardiology, St Anna Hospital, Como, Italy KEYWORDS
More informationReversion of ventricular tachycardia by pacemaker stimulation
British Heart Journal, 1971, 33, 922-927. Reversion of ventricular tachycardia by pacemaker stimulation M. A. Bennett and B. L. Pentecost From the General Hospital, Birmingham 4 Reversion of ventricular
More informationExternal cardioversion of atrial fibrillation: role of paddle position on technical eycacy and energy requirements
726 Department of Cardiology, Ospedale Sant Anna, Via Napoleona 60, 22100 Como, Italy G L Botto A Politi W Bonini T BroVoni R Bonatti Correspondence to: Dr Botto email: ccaec@tin.it Accepted for publication
More informationThe prevalence of atrial fibrillation (AF), already the most common sustained cardiac arrhythmia,
Electrophysiology ATRIAL FIBRILLATION: CLASSIFICATION, PATHOPHYSIOLOGY, MECHANISMS AND DRUG TREATMENT See end of article for authors affiliations Correspondence to: Dr Vias Markides, Waller Cardiac Department,
More informationIn Whom and When Should Atrial Fibrillation Ablation be Considered?
In Whom and When Should Atrial Fibrillation Ablation be Considered? Christian de Chillou, MD, PhD Department of Cardiology University Hospital Nancy, France ESC 2010 Stockholm, August 30. 2010 2 In Whom?
More informationSupplementary Online Content
Supplementary Online Content Verma A, Champagne J, Sapp J, et al. Asymptomatic episodes of atrial fibrillation before and after catheter ablation: a prospective, multicenter study. JAMA Intern Med. Published
More informationClinical Results with the Dual-Chamber Cardioverter Defibrillator Phylax AV - Efficacy of the SMART I Discrimination Algorithm
April 2000 107 Clinical Results with the Dual-Chamber Cardioverter Defibrillator Phylax AV - Efficacy of the SMART I Discrimination Algorithm B. MERKELY Semmelweis University, Dept. of Cardiovascular Surgery,
More informationSynopsis of Management on Ventricular arrhythmias. M. Soni MD Interventional Cardiologist
Synopsis of Management on Ventricular arrhythmias M. Soni MD Interventional Cardiologist No financial disclosure Premature Ventricular Contraction (PVC) Ventricular Bigeminy Ventricular Trigeminy Multifocal
More informationNEIL CISPER TECHNICAL FIELD ENGINEER ICD/CRTD BASICS
NEIL CISPER TECHNICAL FIELD ENGINEER ICD/CRTD BASICS OBJECTIVES Discuss history of ICDs Review the indications for ICD and CRT therapy Describe basic lead and device technology Discuss different therapies
More informationRecurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm
Recurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm Guy Amit, MD, MPH Soroka University Medical Center Ben-Gurion University of the Negev Beer-Sheva, Israel Disclosures Consultant:
More informationVentricular Tachycardia in Structurally Normal Hearts (Idiopathic VT) Patient Information
Melbourne Heart Rhythm Ventricular Tachycardia in Structurally Normal Hearts (Idiopathic VT) Patient Information What is Ventricular Tachycardia? Ventricular tachycardia (VT) is an abnormal rapid heart
More informationAtrial fibrillation: a key determinant in the cardiovascular risk continuum. u Prof. Joseph S. Alpert u Arizona, USA
Atrial fibrillation: a key determinant in the cardiovascular risk continuum u Prof. Joseph S. Alpert u Arizona, USA Disclosures u No major conflicts of interest: all honoraria
More informationManagement strategies for atrial fibrillation Thursday, 20 October :27
ALTHOUGH anyone who has had to run up a flight of steps or has had a frightening experience is quite familiar with a racing heartbeat, for the more than 2 million Americans who suffer from atrial fibrillation
More informationDecember D. EL ALLAF Centre Hospitalier Hutois, Huy, Belgium. P. ATTUEL Centre Chirurgical Val d'or, Saint Cloud, France
December 2000 449 European Multicenter Study on the Prevention of Paroxysmal Atrial Fibrillation by Permanent Overdrive Pacing: Atrial Rate Behavior and Patient Tolerance D. EL ALLAF Centre Hospitalier
More informationIntraoperative and Postoperative Arrhythmias: Diagnosis and Treatment
Intraoperative and Postoperative Arrhythmias: Diagnosis and Treatment Karen L. Booth, MD, Lucile Packard Children s Hospital Arrhythmias are common after congenital heart surgery [1]. Postoperative electrolyte
More informationCardiac Electrical Therapies. By Omar AL-Rawajfah, PhD, RN
Cardiac Electrical Therapies By Omar AL-Rawajfah, PhD, RN Outlines What are cardiac electrical therapies Ablation Defibrillation Cardioversion What are the nursing considerations for each type of therapy
More informationEBR Systems, Inc. 686 W. Maude Ave., Suite 102 Sunnyvale, CA USA
Over 200,000 patients worldwide are estimated to receive a CRT device each year. However, limitations prevent some patients from benefiting. CHALLENGING PROCEDURE 5% implanted patients fail to have coronary
More informationRate and Rhythm Control of Atrial Fibrillation
Rate and Rhythm Control of Atrial Fibrillation April 21, 2017 춘계심혈관통합학술대회 Jaemin Shim, MD, PhD Arrhythmia Center Korea University Anam Hospital Treatment of AF Goal Reducing symptoms Preventing complication
More informationTranscoronary Chemical Ablation of Atrioventricular Conduction
757 Transcoronary Chemical Ablation of Atrioventricular Conduction Pedro Brugada, MD, Hans de Swart, MD, Joep Smeets, MD, and Hein J.J. Wellens, MD In seven patients with symptomatic atrial fibrillation
More informationEHRA Accreditation Exam - Sample MCQs Cardiac Pacing and ICDs
EHRA Accreditation Exam - Sample MCQs Cardiac Pacing and ICDs Dear EHRA Member, Dear Colleague, As you know, the EHRA Accreditation Process is becoming increasingly recognised as an important step for
More informationA trial fibrillation (AF) is a common arrhythmia in
534 CARDIOVASCULAR MEDICINE Sinus rhythm maintenance following DC cardioversion of atrial fibrillation is not improved by temporary precardioversion treatment with oral verapamil C-J A Lindholm, O Fredholm,
More informationAmiodarone Prescribing and Monitoring: Back to the Future
Amiodarone Prescribing and Monitoring: Back to the Future Subha L. Varahan, MD, FHRS, CCDS Electrophysiologist Oklahoma Heart Hospital Oklahoma City, OK Friday, February, 8 th, 2019 Iodinated benzofuran
More informationThe patient with electric storm
The complex patient in the cardiac care unit: The patient with electric storm Helmut U. Klein University of Rochester Medical Center Heart Research Follow-up Program and Isar Heart Center Muenchen Presenter
More informationAF Today: W. For the majority of patients with atrial. are the Options? Chris Case
AF Today: W hat are the Options? Management strategies for patients with atrial fibrillation should depend on the individual patient. Treatment with medications seems adequate for most patients with atrial
More informationAtrial fibrillation (AF) is a disorder seen
This Just In... An Update on Arrhythmia What do recent studies reveal about arrhythmia? In this article, the authors provide an update on atrial fibrillation and ventricular arrhythmia. Beth L. Abramson,
More informationA Cardiology Department, Evangelismos General Hospital, Athens, Greece
Hellenic J Cardiol 47: 72-77, 2006 Clinical Research Study of Atrial Function Using Echocardiographic Automatic Boundary Detection Following External or Internal Cardioversion for Idiopathic Atrial Fibrillation
More informationAtrial Fibrillation 10/2/2018. Depolarization & ECG. Atrial Fibrillation. Hemodynamic Consequences
Depolarization & ECG Atrial Fibrillation How to make ORDER out of CHAOS Julia Shih, VMD, DACVIM (Cardiology) October 27, 2018 Depolarization & ECG Depolarization & ECG Atrial Fibrillation Hemodynamic Consequences
More informationTime to Cardioversion of Recurrent Atrial Arrhythmias After Catheter Ablation of Atrial Fibrillation and Long-Term Clinical Outcome
Time to Cardioversion of Recurrent Atrial Arrhythmias After Catheter Ablation of Atrial Fibrillation and Long-Term Clinical Outcome TIMIR S. BAMAN, M.D., SANJAYA K. GUPTA, M.D., SREEDHAR R. BILLAKANTY,
More informationNewer pacemakers also can monitor your blood temperature, breathing, and other factors and adjust your heart rate to changes in your activity.
Pacemakers & Defibrillators A pacemaker system consists of a battery, a computerized generator and wires with sensors called electrodes on one end. The battery powers the generator, and both are surrounded
More informationUnderstanding Atrial Fibrillation A guide for patients
Understanding Atrial Fibrillation A guide for patients Your doctor has determined that you have atrial fibrillation (AF), a common disturbance of the heart s rhythm. This pamphlet will answer many of your
More informationCARDIOINSIGHT TM NONINVASIVE 3D MAPPING SYSTEM CLINICAL EVIDENCE SUMMARY
CARDIOINSIGHT TM NONINVASIVE 3D MAPPING SYSTEM CLINICAL EVIDENCE SUMMARY April 2017 SUPPORTING EVIDENCE RHYTHM AF VT PUBLICATIONS Driver Domains in Persistent Atrial Fibrillation (Haissaiguerre, et al)
More information3/23/2018. Complications of VAD Therapy: Arrhythmias. Disclosures. Agenda. I have no relevant disclosures
March 23, 2018 Complications of VAD Therapy: Arrhythmias Sandeep M. Jani, MD, MPH Associate Directory of Advanced Heart Failure and Population Health MedStar Heart and Vascular Institute - Baltimore Sandeep
More informationThe pill-in-the-pocket strategy for paroxysmal atrial fibrillation
The pill-in-the-pocket strategy for paroxysmal atrial fibrillation KONSTANTINOS P. LETSAS, MD, FEHRA LABORATORY OF CARDIAC ELECTROPHYSIOLOGY EVANGELISMOS GENERAL HOSPITAL OF ATHENS ARRHYTHMIAS UPDATE,
More informationPARAD/PARAD+ : P and R Based Arrhythmia Detection
Tech Corner PARAD/PARAD+ : P and R Based Arrhythmia Detection NOTE: PLEASE NOTE THAT THE FOLLOWING INFORMATION IS A GENERAL DESCRIPTION OF THE FUNCTION. DETAILS AND PARTICULAR CASES ARE NOT DESCRIBED IN
More informationAF ABLATION Concepts and Techniques
AF ABLATION Concepts and Techniques Antony F Chu, M.D. Director of Complex Ablation Arrhythmia Services Section Division of Cardiology at the Rhode Island and Miriam Hospital HIGHLIGHTS The main indications
More informationIt has been shown that angiotensin-converting enzyme
Angiotensin II Antagonist Prevents Electrical Remodeling in Atrial Fibrillation Hideko Nakashima, MD; Koichiro Kumagai, MD; Hidenori Urata, MD; Naoki Gondo, MD; Munehito Ideishi, MD; Kikuo Arakawa, MD
More informationInvasive and Medical Treatments for Atrial Fibrillation. Thomas J Dresing, MD Section of Electrophysiology and Pacing Cleveland Clinic
Invasive and Medical Treatments for Thomas J Dresing, MD Section of Electrophysiology and Pacing Cleveland Clinic Disclosures Fellow s advisory panel for St Jude Medical Speaking honoraria from: Boston
More informationRadiofrequency Energy: Irrigation and Alternate Catheters. Andreas Pflaumer
Radiofrequency Energy: Irrigation and Alternate Catheters Andreas Pflaumer Irrigated tip RF ablation Irrigated tip How does it work? Potential benefits? Potential risks? How is this relevant to pediatric
More informationCardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition
Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac
More informationInterventional solutions for atrial fibrillation in patients with heart failure
Interventional solutions for atrial fibrillation in patients with heart failure Advances in Cardiovascular Arrhythmias Great Innovations in Cardiology Matteo Anselmino, MD PhD Division of Cardiology Department
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure (review
More informationArrhythmia 341. Ahmad Hersi Professor of Cardiology KSU
Arrhythmia 341 Ahmad Hersi Professor of Cardiology KSU Objectives Epidemiology and Mechanisms of AF Evaluation of AF patients Classification of AF Treatment and Risk stratification of AF Identify other
More informationPreventive Pacing in Atrial Fibrillation
358 September 2001 Preventive Pacing in Atrial Fibrillation W. KAINZ Department of Cardiology, Hanusch Hospital, Vienna, Austria Summary Patients with paroxysmal atrial fibrillation are often highly symptomatic,
More informationAortic Dissection Causes of Death
Aortic Dissection Causes of Death Rupture aorta 33.3% Unspecified 33.3% Neurological l deficit it 13.9% Visceral ischemia/kidney failure 11.5% Cardiac tamponade 7.9% (Circulation 2002;105:200-6) Medical
More informationCombined catheter ablation and left atrial appendage closure as a. treatment of atrial fibrillation
Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation Giulio Molon, MD FACC, FESC, Fellow ANMCO Card Dept, S.Cuore hospital Negrar
More informationΚατάλυση παροξυσμικής κολπικής μαρμαρυγής Ποια τεχνολογία και σε ποιους ασθενείς; Χάρης Κοσσυβάκης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ.
Κατάλυση παροξυσμικής κολπικής μαρμαρυγής Ποια τεχνολογία και σε ποιους ασθενείς; Χάρης Κοσσυβάκης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ. ΓΕΝΝΗΜΑΤΑΣ» Rhythm control antiarrhythmic drugs vs catheter ablation Summary
More informationPERIOPERATIVE MANAGEMENT: CARDIAC PACEMAKERS AND DEFIBRILLATORS
PERIOPERATIVE MANAGEMENT: CARDIAC PACEMAKERS AND DEFIBRILLATORS DR SUSAN CORCORAN CARDIOLOGIST ONCE UPON A TIME.. Single chamber pacemakers Programmed at 70/min VVI 70 UNIPOLAR SYSTEMS A Unipolar Pacing
More informationFrom the Division of Cardiology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan
Reprinted with permission from JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Volume 13, No. 7, July 2002 Copyright 2002 by Futura Publishing Company, Inc., Armonk, NY 10504-0418 Mechanistic Signi cance
More informationKadlec Regional Medical Center Cardiac Electrophysiology
Definition of electrophysiology study and ablation Kadlec Regional Medical Center Cardiac Electrophysiology Electrophysiology Study and Ablation An electrophysiology, or EP, study is a test of the heart
More informationElectrophysiologic Properties of Pulmonary Veins Assessed Using a Multielectrode Basket Catheter
Journal of the American College of Cardiology Vol. 43, No. 12, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.01.051
More informationEtienne Aliot. University of Nancy - France
Etienne Aliot University of Nancy - France Disclosures Consulting fees : - Bayer, Boehringer Ingelheim,GSK, MedaPharma, Pfizer/BMS,Sanofi Aventis. - Biotronik,Medtronic,St Jude Medical. Electrical vs Pharmacological
More informationNational Horizon Scanning Centre. Dronedarone (Multaq) for atrial fibrillation and atrial flutter. December 2007
Dronedarone (Multaq) for atrial fibrillation and atrial flutter December 2007 This technology summary is based on information available at the time of research and a limited literature search. It is not
More information480 April 2004 PACE, Vol. 27
Incremental Value of Isolating the Right Inferior Pulmonary Vein During Pulmonary Vein Isolation Procedures in Patients With Paroxysmal Atrial Fibrillation HAKAN ORAL, AMAN CHUGH, CHRISTOPH SCHARF, BURR
More informationWide QRS Tachycardia in a Dual Chamber Pacemaker Patient: What is the Mechanism?
CASE REPORTS Arrhythmia 2015;16(3):173-177 doi: http://dx.doi.org/10.18501/arrhythmia.2015.029 Wide QRS Tachycardia in a Dual Chamber Pacemaker Patient: What is the Mechanism? Eun-Sun Jin, MD, PhD Cardiovascular
More informationElectrical remodeling of the atrium has been clearly
Electrical Remodeling of the Atria Associated With Paroxysmal and Chronic Atrial Flutter Paul B. Sparks, MBBS, PhD; Shenthar Jayaprakash, MD; Jitendra K. Vohra, MD; Jonathan M. Kalman, MBBS, PhD Background
More informationAbout atrial fibrillation (AFib) Atrial Fibrillation (AFib) What is AFib? What s the danger? Who gets AFib?
Understanding AFib Atrial Fibrillation (AFib) About AFib 3 How Your Heart Works 4 Types of AFib 5 Symptoms 5 Risk Factors 5 How is AFib Diagnosed? 6 Treatment 6 What to Ask Your Doctor 7 A normal heartbeat
More informationRecent studies suggest that atrial fibrillation (AF) is not a
Atrial Fibrillation Detection and R-Wave Synchronization by Metrix Implantable Atrial Defibrillator Implications for Long-Term Efficacy and Safety Hung-Fat Tse, MB, BS; Chu-Pak Lau, MD; Jasbir S. Sra,
More information2017 AHA/ACC/HRS Ventricular Arrhythmias and Sudden Cardiac Death Guideline. Top Ten Messages. Eleftherios M Kallergis, MD, PhD, FESC
2017 AHA/ACC/HRS Ventricular Arrhythmias and Sudden Cardiac Death Guideline Top Ten Messages Eleftherios M Kallergis, MD, PhD, FESC Cadiology Department - Heraklion University Hospital No actual or potential
More informationNew generations pacemakers and ICDs: an update
Advances in Cardiac Arrhythmias and Great Innovations in Cardiology XXVII Giornate Cardiologiche Torinesi New generations pacemakers and ICDs: an update Prof. Fiorenzo Gaita, MD Division of Cardiology
More informationWhat s new in my specialty?
What s new in my specialty? Jon Melman, MD Heart Rhythm Specialists McKay-Dee Hospital some would say some would say my specialty 1 some would say my specialty First pacemaker 1958 some would say my specialty
More informationKomplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents
Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents Prof. Dr. med. Julinda Mehilli Medizinische Klinik und Poliklinik I Klinikum der Universität München Campus Großhadern Key Factors
More informationAF in the ER: Common Scenarios CASE 1. Fast facts. Diagnosis. Management
AF in the ER: Common Scenarios Atrial fibrillation is a common problem with a wide spectrum of presentations. Below are five common emergency room scenarios and the management strategies for each. Evan
More informationRecent observations have focused attention on the PVs as a source of ectopic activity i determining i AF
Atrial Fibrillation in 2010 Panos Vardas Professor of Cardiology President of EHRA Atrial Fibrillation Pathophysiology of AF Triggers Recent observations have focused attention on the PVs as a source of
More informationIndex. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A AADs. See Antiarrhythmic drugs (AADs) ACE inhibitors. See Angiotensin-converting enzyme (ACE) inhibitors ACP in transseptal approach to
More informationThe patient with (without) an ICD and heart failure: Management of electrical storm
ISHNE Heart Failure Virtual Symposium April 2008 The patient with (without) an ICD and heart failure: Management of electrical storm Westfälische Wilhelms-Universität Münster Günter Breithardt, MD, FESC,
More informationΚΑΤΑΛΥΣΗ ΚΟΛΠΙΚΗΣ ΜΑΡΜΑΡΥΓΗΣ. ΥΠΕΡ. Michalis Efremidis MD Second Department of Cardiology Evangelismos General Hospital
ΚΑΤΑΛΥΣΗ ΚΟΛΠΙΚΗΣ ΜΑΡΜΑΡΥΓΗΣ. ΥΠΕΡ. Michalis Efremidis MD Second Department of Cardiology Evangelismos General Hospital Rate control versus Rhythm control for Atrial Fibrillation AFFIRM N Engl J Med 2002;347:1825-33
More informationManagement of ATRIAL FIBRILLATION. in general practice. 22 BPJ Issue 39
Management of ATRIAL FIBRILLATION in general practice 22 BPJ Issue 39 What is atrial fibrillation? Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in primary care. It is often
More informationJournal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 37, No. 2, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)01133-5 Coronary
More information